Orgenesis Inc. Faces Delisting Notice
Ticker: ORGS · Form: 8-K · Filed: Jun 6, 2025 · CIK: 1460602
| Field | Detail |
|---|---|
| Company | Orgenesis INC. (ORGS) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
TL;DR
Orgenesis got a delisting warning, might be in trouble.
AI Summary
Orgenesis Inc. filed an 8-K on June 6, 2025, to report a notice of delisting or failure to satisfy continued listing rules. The company, incorporated in Nevada with its principal executive offices in Germantown, MD, is in the Pharmaceutical Preparations industry.
Why It Matters
This filing indicates potential issues with Orgenesis Inc.'s continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards suggests significant financial or operational distress for the company.
Key Players & Entities
- Orgenesis Inc. (company) — Registrant
- June 6, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- Germantown, MD (location) — Principal executive offices
- 001-38416 (identifier) — Commission File Number
- 98-0583166 (identifier) — IRS Employer Identification No.
FAQ
What specific rule or standard has Orgenesis Inc. failed to satisfy, leading to this notice?
The filing does not specify the exact rule or standard that Orgenesis Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the expected timeline for Orgenesis Inc. to address the listing deficiency?
The filing does not provide information on the expected timeline for Orgenesis Inc. to address the listing deficiency.
Has Orgenesis Inc. taken any steps to rectify the situation that led to this notice?
The filing does not detail any specific steps Orgenesis Inc. has taken to rectify the situation.
What are the potential consequences for Orgenesis Inc. if the listing deficiency is not resolved?
The potential consequences, as indicated by the filing, include delisting from the exchange where the company's securities are traded.
Does this filing indicate any immediate impact on Orgenesis Inc.'s operations or financial health?
While the filing signals potential future impacts due to listing issues, it does not directly detail immediate operational or financial health impacts beyond the notice itself.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding Orgenesis Inc. (ORGS).